284 related articles for article (PubMed ID: 29059470)
21. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
[TBL] [Abstract][Full Text] [Related]
22. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
[TBL] [Abstract][Full Text] [Related]
23. Prp19 facilitates invasion of hepatocellular carcinoma via p38 mitogen-activated protein kinase/twist1 pathway.
Yin J; Wang L; Zhu JM; Yu Q; Xue RY; Fang Y; Zhang YA; Chen YJ; Liu TT; Dong L; Shen XZ
Oncotarget; 2016 Apr; 7(16):21939-51. PubMed ID: 26959880
[TBL] [Abstract][Full Text] [Related]
24. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
[TBL] [Abstract][Full Text] [Related]
25. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
26. Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.
Tremosini S; Forner A; Boix L; Vilana R; Bianchi L; Reig M; Rimola J; Rodríguez-Lope C; Ayuso C; Solé M; Bruix J
Gut; 2012 Oct; 61(10):1481-7. PubMed ID: 22287594
[TBL] [Abstract][Full Text] [Related]
27. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
[TBL] [Abstract][Full Text] [Related]
28. STK33 promotes hepatocellular carcinoma through binding to c-Myc.
Yang T; Song B; Zhang J; Yang GS; Zhang H; Yu WF; Wu MC; Lu JH; Shen F
Gut; 2016 Jan; 65(1):124-33. PubMed ID: 25398772
[TBL] [Abstract][Full Text] [Related]
29. Gelsolin-like Actin-capping Protein (CapG) Overexpression in the Cytoplasm of Human Hepatocellular Carcinoma, Associated with Cellular Invasion, Migration and Tumor Prognosis.
Tsai TJ; Chao WY; Chen CC; Chen YJ; Lin CY; Lee YR
Anticancer Res; 2018 Jul; 38(7):3943-3950. PubMed ID: 29970516
[TBL] [Abstract][Full Text] [Related]
30. Tissue microarray-based study of hepatocellular carcinoma validating SPIB as potential clinical prognostic marker.
Ho YJ; Lin YM; Huang YC; Yeh KT; Lin LI; Lu JW
Acta Histochem; 2016 Jan; 118(1):38-45. PubMed ID: 26610895
[TBL] [Abstract][Full Text] [Related]
31. Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular Carcinoma.
Naboulsi W; Megger DA; Bracht T; Kohl M; Turewicz M; Eisenacher M; Voss DM; Schlaak JF; Hoffmann AC; Weber F; Baba HA; Meyer HE; Sitek B
J Proteome Res; 2016 Jan; 15(1):38-47. PubMed ID: 26626371
[TBL] [Abstract][Full Text] [Related]
32. Early HCC: diagnosis and molecular markers.
Sakamoto M
J Gastroenterol; 2009; 44 Suppl 19():108-11. PubMed ID: 19148803
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
Zhu M; Li M; Wang T; Linghu E; Wu B
Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
[TBL] [Abstract][Full Text] [Related]
34. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
35. Cyclin dependent kinase inhibitor p27(kip1) expression and subcellular localization in relation to cell proliferation in hepatocellualr carcinoma.
Shehata MA; Nosseir HR; Nagy HM; Farouk G
Egypt J Immunol; 2006; 13(1):115-30. PubMed ID: 17974156
[TBL] [Abstract][Full Text] [Related]
36. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma.
Chuma M; Sakamoto M; Yamazaki K; Ohta T; Ohki M; Asaka M; Hirohashi S
Hepatology; 2003 Jan; 37(1):198-207. PubMed ID: 12500205
[TBL] [Abstract][Full Text] [Related]
37. PCBP1 regulates the transcription and alternative splicing of metastasis‑related genes and pathways in hepatocellular carcinoma.
Huang S; Luo K; Jiang L; Zhang XD; Lv YH; Li RF
Sci Rep; 2021 Dec; 11(1):23356. PubMed ID: 34857818
[TBL] [Abstract][Full Text] [Related]
38. EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies.
Cai MY; Tong ZT; Zheng F; Liao YJ; Wang Y; Rao HL; Chen YC; Wu QL; Liu YH; Guan XY; Lin MC; Zeng YX; Kung HF; Xie D
Gut; 2011 Jul; 60(7):967-76. PubMed ID: 21330577
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
40. Mastermind-like Transcriptional Coactivator 1 Overexpression Predicts Poor Prognosis in Human with Hepatocellular Carcinoma.
Wang J; Zhang SM; Wu JM; Lu ZC; Yang JR; Wu HS; Chen H; Lin B; Xu RH; Cao TS
Ann Clin Lab Sci; 2016 Sep; 46(5):502-7. PubMed ID: 27650617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
